| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| ifabotuzumab | ephrin type-a receptor 3 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] MYELODYSPLASTIC SYNDROME[MeSHID:D009190] Leukemia Myelocytic Acute[MeSHID:D015470] Recurrence (disease attribute)[MeSHID:D012008] Glioblastoma[MeSHID:D005909] |
NA | phase 2 | unknown |
| click here to return to the previous page | ||||||||